Plastic and Reconstructive Surgery, Global Open (Mar 2022)

Preventing Infection in Implant-based Breast Reconstruction: Evaluating the Evidence for Common Practices and Standardized Protocols

  • Nusaiba F. Baker, PhD,
  • Owen Brown, MD,
  • Alexandra M. Hart, MD,
  • Dora Danko, BS,
  • Christopher M. Stewart, MD,
  • Peter W. Thompson, MD

DOI
https://doi.org/10.1097/GOX.0000000000004208
Journal volume & issue
Vol. 10, no. 3
p. e4208

Abstract

Read online

Background:. Infection following implant-based breast reconstruction (IBBR) results in increased rates of hospital readmission, reoperation, patient and hospital expenses, and reconstructive failure. IBBR is a complex, multistep procedure, and there is a relative lack of high-quality plastic surgery evidence regarding “best practices” in the prevention of implant infections. In the absence of strong data, standardizing procedures based on available evidence can reduce error and improve efficacy and outcomes. Methods:. We performed a focused literature review of the available evidence supporting specific interventions for infection prevention in the preoperative, intraoperative, and postoperative phases of care that are applicable to IBBR. In addition, we examined previously published standardized perioperative protocols for implant reconstruction. Results:. Preoperative, intraoperative, and postoperative planning and organization is crucial in IBBR. Preoperative planning involves skin decolonization in advance of surgery with either chlorhexidine gluconate or mupirocin. Intraoperative methods that have shown potential benefit include double-gloving, breast pocket irrigation, separate closing instruments, and the utilization of “no-touch” techniques. In the postoperative period, the duration of drain removal and postoperative antibiotic administration play an important role in the prevention of surgical site infection. Conclusions:. There is a crucial need to establish an evidence-based set of “best practices” for IBBR, and there exists a paucity of evidence in the breast literature. These data can be utilized to develop a standardized protocol as part of a rigorous quality improvement methodology.